跳至主要内容
临床试验/NL-OMON40036
NL-OMON40036已完成不适用

Prospective Assessment of Risk Factors for Appropriate ICD Intervention in Patients with Ischemic Cardiomyopathy . - PARCADIA

Biotronik0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Biotronik
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • *Patient with ischemic cardiomyopathy with an indication for de novo ICD implantation for primary prevention, according to ESC guidelines or local standards (MADIT II population)
  • *Written informed consent / willingness and ability to comply with the protocol

排除标准

  • *Contraindication for MRI
  • *Severe renal dysfunction (if leading to a contraindication for the admission of Gadolinium with MRI)
  • *Indication for secondary prevention ICD implantation
  • *Class I indication for CRT-D
  • *Heart failure with New York Heart Association functional class IV
  • *LV ejection fraction >40%
  • *Age <18 years and >85 years
  • *Women that are pregnant, lactating or planning to become pregnant
  • *Participating in any other clinical trial with active intervention(s) during the course of this clinical investigation
  • *Life expectancy less than 1 year

研究者

发起方
Biotronik

相似试验